Pattern Scanning Laser Trabeculoplasty Program Obtains FDA Clearance for the Pascal Synthesis and TwinStar

Topcon Medical Systems announced that its proprietary software, Pattern Scanning Laser Trabeculoplasty (PSLT), for the reduction of IOP associated with glaucoma, has obtained FDA clearance for use with the »Synthesis and TwinStar models of their Pattern Scanning Lasers. 

PSLT, formerly available only in the Streamline model, is an advanced tissue-sparing laser treatment for reducing IOP in open angle glaucoma. PSLT provides a rapid, precise, and minimally traumatic computer-guided treatment that applies a sequence of patterns onto the trabecular meshwork. Automated rotation of consecutive patterns ensures that treatment steps are precisely placed without overlap or excessive gaps. Clinical studies of PSLT show an average IOP reduction of 24% in 6 months.

“By providing a computer-guided approach using PSLT, the PASCAL system makes laser treatment of the anterior segment, a sometimes-challenging task, very manageable,” Dr. Sandra BelalcazarRey, Universidad del Rosario, Bogotá, Colombia, said in a news release. Dr. Kaweh Mansouri, Montchoisi Clinic, Switzerland, further adds, “My experience with PSLT offers comparable safety and efficacy with less patient discomfort.” 

“The availability of PSLT now offers a clinically-proven treatment technology for open angle glaucoma to ophthalmologists in the United States,” said Robert Gibson, Vice President, Eye Care Global Marketing, Topcon Corporation. “Globally, we’ve seen success with the Streamline and TwinStar PSLT application and believe glaucoma specialists and comprehensive ophthalmologists in the United States will find this technology a useful addition to their treatment armamentarium.” 

To learn more about the PSLT technique, visit www.pascalvision.com.